Opal Wealth Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$37.5K	Buy	330 +25	+8%	+$2.84K	0.01%	424
2025 Q1	$32.1K	Buy	+305	New	+$32.1K	0.01%	431
2024 Q3	–	Sell	-207	Closed	-$17.4K	–	745
2024 Q2	$17.4K	Buy	+207	New	+$17.4K	0.01%	543